Expression of WNT10A in papillary thyroid carcinoma and its effect on cell proliferation, invasion, and metastasis.
10.11817/j.issn.1672-7347.2025.240237
- Author:
Li YUAN
1
,
2
;
Ping ZHOU
3
;
Yongfeng ZHAO
3
;
Jiale LI
3
;
Yan ZHANG
3
;
Wengang LIU
3
,
4
Author Information
1. Department of Nuclear Medicine, Third Xiangya Hospital, Central South University, Changsha 410013, China. li_yuan2019@
2. com.
3. Department of Ultrasound, Third Xiangya Hospital, Central South University, Changsha
4. liuwengang312@hotmail.com.
- Publication Type:Journal Article
- Keywords:
Tec kinase signaling pathway;
WNT10A;
invasion;
metastasis;
papillary thyroid carcinoma;
proliferation
- MeSH:
Humans;
Cell Proliferation;
Thyroid Cancer, Papillary/pathology*;
Thyroid Neoplasms/metabolism*;
Animals;
Wnt Proteins/metabolism*;
Neoplasm Invasiveness;
Mice;
Cell Line, Tumor;
Female;
Male;
Mice, Nude;
Apoptosis;
Lymphatic Metastasis;
Middle Aged;
Cell Movement;
Adult
- From:
Journal of Central South University(Medical Sciences)
2025;50(3):402-415
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Lymph node metastasis in papillary thyroid cancer (PTC) is closely associated with tumor recurrence and patient survival. However, current technologies have limited sensitivity in detecting occult cervical lymph node metastases. Identifying accurate molecular markers for predicting PTC metastasis holds significant clinical value. This study aims to analyze WNT10A expression in PTC and its clinical significance, and to explore the role of WNT10A gene knockdown in PTC cell proliferation, invasion, and metastasis.
METHODS:The expression of WNT10A in thyroid carcinoma was analyzed using the Gene Expression Profiling Interactive Analysis (GEPIA) and University of Alabama at Birminghara Cancer data analysis Portal (UALCAN) databases. Real-time RT-PCR was used to measure WNT10A mRNA levels in tumor and adjacent normal tissues from 32 PTC patients. Immunohistochemistry was conducted on 158 PTC specimens to assess WNT10A protein expression and its correlation with clinicopathological features. In vitro experiments were performed using K1 and TPC-1 cell lines. Cell proliferation was assessed using the Celigo system and methyl thiazolyl tetrazolium (MTT) assays; apoptosis was measured via flow cytometry; invasion and metastasis were evaluated using scratch and Transwell assays. A xenograft model was established in nude mice to observe tumor growth, and tumor weight and volume were compared between cell lines. Differentially expressed genes regulated by WNT10A were identified via mRNA sequencing, followed by Gene Ontology (GO) and ingenuity pathway analysis (IPA). Real-time PCR and Western blotting were used to validate the effects of WNT10A on key downstream mRNA and protein in the Tec kinase signaling pathway.
RESULTS:WNT10A mRNA expression was significantly higher in thyroid cancer tissues compared to adjacent normal tissues according to GEPIA and UALCAN (both P<0.01). The real-time RT-PCR result showed that WNT10A mRNA expression in PTC tissues was high than that in adjacent tissues (P<0.01). Immunohistochemistry revealed significantly higher WNT10A protein expression in PTC tissues compared to adjacent tissues (P<0.01), and its expression correlated with multifocality, extrathyroidal invasion, and lymph node metastasis. WNT10A knockdown significantly inhibited proliferation, altered cell cycle distribution, and increased apoptosis in K1 and TPC-1 cells (all P<0.01). WNT10A silencing also reduced migration and invasion abilities in both cell lines. In vivo, WNT10A knockdown in TPC-1 cells suppressed tumor formation in nude mice. GO analysis and IPA suggested that the Tec kinase signaling pathway was a key downstream target of WNT10A. RT-PCR and Western blotting confirmed that WNT10A knockdown downregulated the expression of key genes (STAT3, MAPK8, TNFRSF21, and AKT2) in this pathway.
CONCLUSIONS:WNT10A is highly expressed in PTC and is associated with tumor proliferation, invasion, and metastasis. Its tumor-promoting effects may be mediated through suppression of the Tec kinase signaling pathway.
